John Gustofson, MS, MBA appointed to the Board of Directors The appointment is in conjunction with Chugai Venture Fund joining syndicate with an investment that brings Hyku’s total seed financing to ...
Schrödinger, Inc. today announced a research collaboration and license agreement with Novartis to advance multiple development candidates into Novartis's portfolio for further development. The ...
The global sore throat lozenges market is projected to be valued at USD 4.4 billion in 2024 and is expected to grow at a CAGR of 5.6%, reaching an estimated value of approximately USD 7.5 billion by ...
The global antimetabolite drugs market is on track for steady growth, with projections indicating a compound annual growth ...
Hoffmann-La Roche Ltd, Sanofi-Aventis, Bristol-Myers Squibb Company, AbbVie, Inc., Novartis AG, GlaxoSmithKline PLC, Celgene Corporation, Johnson & Johnson Services, Inc., and Takeda Pharmaceutical ...
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of ...
Several key players are shaping the global pruritus therapeutics market. Companies such as Allergan Inc., Amgen Inc., Astellas Pharma Inc., CARA Therapeutics, Novartis AG, and Teva Pharmaceutical ...
Goodwin is presenting a two-part publication series covering life sciences trends involving license deals, M&A, and financing for Greater China’s ...
Q3 2024 Earnings Call Transcript November 9, 2024 Operator: Greetings, and welcome to the Achieve Life Sciences Third Quarter ...
Thailand Pharmaceutical Industry, according to Fitch Solutions, the pharmaceutical market in Southeast Asia has a market size ...
The major players in the market are Hisamitsu Pharmaceuticals, Bayer AG, Novartis AG, Galderma Holding SA, GlaxoSmithKline PLC, Johnson & Johnson Private Limited, Bausch Health Companies Inc., Cipla ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback